| Specialty Retail Industry | Consumer Discretionary Sector | Larry C. Heaton II CEO | OTC PINK Exchange | CA98980M1095 ISIN |
| US Country | 144 Employees | - Last Dividend | - Last Split | 29 Jul 2016 IPO Date |
Zomedica Corp. is a dedicated veterinary health company that addresses the unmet clinical needs of veterinarians. Focused on companion animals, Zomedica develops innovative products aimed at improving veterinary care. The company is committed to enhancing the capabilities of clinical practice through groundbreaking technology and solutions. Headquartered in Ann Arbor, Michigan, Zomedica was founded in 2015 and was previously known as Zomedica Pharmaceuticals Corp. In October 2020, the company rebranded itself to reflect its focus on veterinary health.
The TRUFORMA platform is an advanced point-of-care diagnostic system designed for veterinarians. It provides dynamic testing solutions for a variety of disease states affecting dogs and cats, enabling timely and informed decision-making in clinical practice.
PulseVet offers therapeutic solutions for musculoskeletal conditions in both horses and small animals. This treatment addresses issues such as broken bones, tendonitis, and torn ligaments, helping to improve mobility and recovery for affected animals.
In collaboration with Celsee, Inc., Zomedica is developing and commercializing innovative liquid biopsy assays. These diagnostics aim to detect cancer in companion animals, leading to earlier and more effective treatment options for pets diagnosed with cancer.
In partnership with Seraph Biosciences, Inc., Zomedica is working on a novel pathogen detection system. This system is designed to identify harmful pathogens in companion animals, enhancing diagnosis and treatment efficiency in veterinary practices.